SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarey Drugs & Pharmaceuticals informs about outcome of board meeting

20 Mar 2018 Evaluate

Aarey Drugs & Pharmaceuticals has informed that the Committee of the Board of the Company at its meeting held today has approved the issue price of Rs 54.93 per Equity share (including premium of Rs 44.93 per Equity share) for issuance & allocation of 33,00,000 Equity shares to eligible Qualified Institutional Buyers in the Qualified Institutional Placement, aggregating to Rs 1,812.69 Lakhs; approved and adopted the Placement document dated March 20, 2018, in connection with the Issue, (the ‘Placement Document’); and approved the issue of confirmation of allocation notes to Qualified Institutional Buyers.

The above information is a part of company’s filings submitted to BSE.

 

Aarey Drugs & Pharma Share Price

82.15 3.47 (4.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×